The current valuation score of Kura Oncology Inc is 6.71, ranking 263 out of 385 in the Biotechnology & Medical Research industry. Its current P/E ratio is -2.69, which is -9.60% below the recent high of -2.43 and -319.61% above the recent low of -11.29.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.